IUPAC_name = (2"E",4"E",6"Z",8"E")-3,7-dimethyl-9-(2,6,6-trimethyl-
1-cyclohexenyl)nona-2,4,6,8-tetraenoic acid

CAS_number = 5300-03-8
ATC_prefix = L01
ATC_suffix = XX22
ATC_supplemental = ATC|D11|AX19 [cite web |url= |title=ATC/DDD Classification (FINAL): New ATC 5th level codes |date=August 27, 2008 |author=WHO International Working Group for Drug Statistics Methodology |publisher=WHO Collaborating Centre for Drug Statistics Methodology |accessdate=2008-09-05]
PubChem = 449171
DrugBank = APRD00017
C = 20 | H = 28 | O = 2
molecular_weight = 300.435 g/mol
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category =
legal_AU =
legal_UK =
legal_US =
legal_status = Rx only
routes_of_administration = Topical

Alitretinoin (tradename Panretin) is an antineoplastic agent developed by Ligand Pharmaceuticals.

It is a first generation retinoid.

Clinical uses

Alitretinoin is indicated for the topical treatment of cutaneous lesions in patients with AIDS-related Kaposi’s sarcoma. It is not indicated when systemic anti-KS therapy is required (e.g., more than 10 new KS lesions in the prior month, symptomatic lymphedema, symptomatic pulmonary KS, or symptomatic visceral involvement). There is no experience to date using alitretinoin with systemic anti-KS treatment.


Ligand gained Food and Drug Administration (FDA) approval for alitretinoin in February 1999. Vol. 140 No. 12, December 2004 Archives • Online Features Under the trade name 'Toctino' it has been granted prescription rights in the UK (08/09/2008) for use in Chronic Hand Eczema. It is manufactured by Basilea of Switzerland. (BAL4079)Oral Alitretinoin (9-cis-Retinoic Acid) Therapy for Chronic Hand Dermatitis in Patients Refractory to Standard Therapy Results of a Randomized, Double-blind, Placebo-Controlled, Multicenter Trial

Thomas Ruzicka, MD; Frederik Grønhøj Larsen, MD, PhD; Dorota Galewicz, MD; Attila Horváth, MD; Peter Jan Coenraads, MD; Kristian Thestrup-Pedersen, MD; Jean Paul Ortonne, MD; Christos C. Zouboulis, MD; Martin Harsch, PhD; Thomas C. Brown, PhD; Maurice Zultak, MD

Arch Dermatol. 2004;140:1453-1459.


External links

* [ Prescribing Information] (revised February 2007). Retrieved on 01-30-08.

Wikimedia Foundation. 2010.

Look at other dictionaries:

  • alitretinoin — noun A particular antineoplastic drug …   Wiktionary

  • alitretinoin — al·i·tret·i·noin (al″ĭ tretґĭ noin″) 9 cis retinoic acid; an endogenous retinoid used as a topical antineoplastic in the treatment of AIDS related cutaneous Kaposi sarcoma …   Medical dictionary

  • Tretinoin — Systematic (IUPAC) name retinoic acid …   Wikipedia

  • ATC code D11 — ATC codes D Dermatologicals D01 Antifungals for dermatological use D02 Emollients and protectives D03 Preparations for treatment of wounds and ulcers D04 Antipruritics, including antihistamines, anesthetics, etc. D05 Antipsoriatics D06 Antibiot …   Wikipedia

  • Dyshidrosis — Classification and external resources …   Wikipedia

  • Basilea Pharmaceutica — AG Rechtsform Aktiengesellschaft ISIN CH0011432447 Gründung …   Deutsch Wikipedia

  • Cheiropompholyx — Klassifikation nach ICD 10 L30.1 Dyshidrosis (Pompholyx) …   Deutsch Wikipedia

  • Dyshidrose — Klassifikation nach ICD 10 L30.1 Dyshidrosis (Pompholyx) …   Deutsch Wikipedia

  • Dyshidrosiformes Ekzem — Klassifikation nach ICD 10 L30.1 Dyshidrosis (Pompholyx) …   Deutsch Wikipedia

  • Dyshidrosis — Klassifikation nach ICD 10 L30.1 Dyshidrosis (Pompholyx) …   Deutsch Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.